铁线虫

罗体：扎尼奥洛右大腿肌肉拉伤缺席3-4周，可能影响9月欧国联比赛_我的网站

A |     8月26日讯 乌迪内斯球员扎尼奥洛右大腿肌肉拉伤，《罗马体育报》称他将因此缺席3至4周时间。在首轮意甲联赛，乌迪内斯主场1-1战平科莫。

B |     

    Medicine File photo: VCG
China has granted marketing approval of its first drug for the prevention of acute mountain sickness, filling the long-standing gap in the domestic market where no such medications had been available, Science and Technology Daily reported on Tuesday.
The National Medical Products Administration (NMPA) has approved the marketing of acetazolamide sustained-release capsules, the report said. As the first specialized drug in China indicated for preventing of acute mountain sickness, its approval marks the end of the country's lack of dedicated preventive treatment for altitude illness. 
By inhibiting the activity of carbonic anhydrase, acetazolamide promotes the renal excretion of bicarbonate, corrects respiratory alkalosis caused by hypoxia at high altitudes, thereby regulating acid-base balance, optimizing respiratory status, elevating blood oxygen levels, and reducing the risk of onset at the source. 
In contrast to health products that only provide auxiliary regulatory effects, this medication has been validated through stringent clinical trials and stands as a specialized drug approved by the NMPA with a clear indication for prevention, said the report.
Led by principal investigator is Luobu Gesang, a deputy dean of the People's Hospital of Xizang Autonomous Region, the clinical trial was designed by his team and has yielded critical evidence to inform prevention strategies for altitude sickness that are specifically adapted to Chinese and Asian populations. 
"Previously, although acetazolamide had already been used internationally for the prevention of acute mountain sickness, China had long lacked an NMPA-approved acetazolamide formulation supported by rigorous clinical trials. Furthermore, the existing international formulations were short-acting tablets requiring multiple daily doses, and no drugs with the relevant indication were available on the domestic market for an extended period," said Luobu Gesang.
The sustained-release capsule approved this time not only fills this critical gap but also optimizes the dosage form, providing more reliable and convenient medication protection for the physical health and life safety of people entering high-altitude areas, he added.
Clinical trials showed that, compared with the placebo group, the incidence of acute mountain sickness in the medication group was significantly reduced, with the incidence of moderate-to-severe acute mountain sickness decreasing by 14.6 percent, according to the report.
Related research has been published in the international flagship journal of high-altitude medicine, High Altitude Medicine & Biology.
Global Times
。扎尼奥洛首发，但他在第90分钟受伤被换下，当时他表示自己“可能拉伤了。”赛后乌迪内斯安排扎尼奥洛接受了详细检查，并确认他的右大腿二头肌拉伤。扎尼奥洛已经开始康复过程，而《罗马体育报》称他将因此缺席3至4周时间。这意味着扎尼奥洛在9月份的国家队比赛日之前都无法复出，甚至有可能影响到意大利国家队的欧国联比赛，这对乌迪内斯和意大利国家队都是个坏消息。此外，乌迪内斯还宣布，18岁的后卫马泰奥·帕尔马也在首轮意甲联赛拉伤了右腿内收肌，将缺席大约一个月。

Current article:http://lmtk.panningbuquanchencaibingzhang.cyou/news/20260826_5284341.html

Published on:22:06:32